OS-053 Fecal microbiota transplantation combined with atezolizumab plus bevacizumab in hepatocellular carcinoma refractory to atezolizumab plus bevacizumab: final results of the open label, single-arm, FAB-HCC pilot study

作者：Katharina Pomej, Adrian Frick, Bernhard Scheiner, Maximilian Baumgartner, Klaus Schmetterer, Lorenz Balcar, Larissa Pajancic, Abelina Kreuter, Petra Pjevac, Joana Paula Pereira Barbosa Roque da Silva, Bela Hausmann, Thomas Köcher, Carlos Reyna-Blanco, Katharina Lampichler, Nataliya Rohr-Udilova, Adrija Chakrabarty, Anton Klotz, Annika Lampl, Kerstin Zinober, Katharina Regnat, Michael Trauner, David Berry, Thomas Vogl, Dietmar Tamandl, Christoph Gasché, Matthias Pinter · 发表于：Journal of Hepatology · 年份：2026 · DOI：10.1016/s0168-8278(26)00363-6 · 被引用次数：1 · 研究领域：Clostridium difficile and Clostridium perfringens research、Gut microbiota and health、Hepatitis B Virus Studies